Cartalax is a synthetic short bioregulatory tripeptide composed of Alanine, Glutamic Acid, and Aspartic Acid (Ala-Glu-Asp). It has been investigated in preclinical research for its potential role in regulating chondrocyte activity, maintaining extracellular matrix homeostasis, and supporting cartilage biology. Experimental studies suggest that Cartalax may influence gene expression and protein synthesis involved in connective tissue maintenance rather than acting as a structural replacement for cartilage components. Ongoing research explores its relevance in models of cartilage aging, extracellular matrix remodeling, and musculoskeletal tissue regulation. All available data are derived from laboratory and preclinical investigations, and further independent studies are required to fully characterize its biological mechanisms and potential applications.

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa FRESHLY PREPARED SOLUTION 

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa

CJC-1295 is a synthetic analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in growth hormone– and insulin-like growth factor 1 (IGF-1)–associated signaling pathways. Experimental studies have examined how incorporation of a Drug Affinity Complex (DAC) may extend the peptide’s plasma persistence, allowing prolonged observation of GH–IGF axis dynamics under controlled laboratory conditions. In preclinical experimental settings, CJC-1295 has been explored in relation to: – protein synthesis–associated anabolic signaling– lipid metabolism and body composition–related biochemical pathways

Modified GRF is a truncated peptide analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in GHRH-mediated signaling pathways. In experimental settings, Modified GRF has been explored in relation to: – muscle repair– and growth-associated cellular signaling – wound-associated tissue remodeling processes – bone metabolism and structural signaling pathways – lipid metabolism and fat-oxidation–related biochemical pathways – metabolic regulation–associated signaling networks – glucose homeostasis– and immune-related regulatory pathways

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.   

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.    FRESHLY PREPARED SOLUTION 

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models  FRESHLY PREPARED SOLUTION 

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models 

Research on Dihexa suggests it has been explored for its potential role in: Supporting neuronal repair mechanisms in experimental models Promoting synaptic connectivity and signaling pathways involved in neural plasticity Enhancing neurotrophic activity associated with growth-factor mediated communication Investigating protective effects in preclinical models of neurodegeneration, including Alzheimer’s- and Parkinson’s-related pathways Supporting cognitive performance parameters such as learning, memory formation, and recall in animal studies Improving motivation- and mood-related behavioral markers in exploratory research models Enhancing mental endurance and sustained attention in cognitive testing paradigms Supporting executive functions such as problem-solving and information processing speed in experimental settings Exploring effects on social recognition and interaction-related behavioral markers in preclinical studies

Research on Dihexa suggests it has been explored for its potential role in: Supporting neuronal repair mechanisms in experimental models Promoting synaptic connectivity and signaling pathways involved in neural plasticity Enhancing neurotrophic activity associated with growth-factor mediated communication Investigating protective effects in preclinical models of neurodegeneration, including Alzheimer’s- and Parkinson’s-related pathways Supporting cognitive performance parameters such as learning, memory formation, and recall in animal studies Improving motivation- and mood-related behavioral markers in exploratory research models Enhancing mental endurance and sustained attention in cognitive testing paradigms Supporting executive functions such as problem-solving and information processing speed in experimental settings Exploring effects on social recognition and interaction-related behavioral markers in preclinical studiesFRESHLY PREPARED SOLUTION

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress. DNSP-11 has been explored in research contexts related to: Dopaminergic neuron degeneration models Nigrostriatal system dysfunction Neuroprotective and neurorestorative pathways Modulation of dopamine and dopamine metabolite levels Motor asymmetry and behavioral outcome models Neuronal survival and anti-apoptotic signaling Neurite outgrowth and neuronal differentiation Toxin-induced neurodegeneration models FRESHLY PREPARED SOLUTION 

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress.DNSP-11 has been explored in research contexts related to:Dopaminergic neuron degeneration modelsNigrostriatal system dysfunctionNeuroprotective and neurorestorative pathwaysModulation of dopamine and dopamine metabolite levelsMotor asymmetry and behavioral outcome modelsNeuronal survival and anti-apoptotic signalingNeurite outgrowth and neuronal differentiationToxin-induced neurodegeneration models

DRP-104 is an experimental compound investigated for its ability to inhibit glutaminase 1 (GLS1), a key enzyme responsible for converting glutamine into glutamate. Because glutamate supports nucleotide synthesis, amino acid production, antioxidant defense, and mitochondrial energy metabolism, GLS1 inhibition can disrupt multiple metabolic pathways essential for tumor growth. Cancer cells frequently depend on glutamine metabolism to sustain rapid proliferation, energy generation, and redox homeostasis. By blocking GLS1, DRP-104 has been explored as a metabolic intervention that induces a state of metabolic stress in tumor cells, potentially reducing their proliferative capacity and promoting selective vulnerability. Research has also investigated DRP-104 for its broader implications in tumor biology, including potential effects on oxidative stress balance, growth signaling pathways such as mTOR, and tumor microenvironment nutrient competition. 

Delta sleep-inducing peptide (DSIP) is a neuropeptide that has been investigated in experimental and preclinical research settings for its involvement in the regulation of multiple endocrine and physiological processes, particularly those related to sleep–wake modulation and adaptive stress responses. Experimental studies suggest that DSIP may be associated with: Modulation of sleep-related physiological processes Regulation of sleep quality under conditions of chronic sleep disruption Adaptive responses to physiological and psychological stress Influence on autonomic and cardiovascular regulatory parameters Modulation of pain-related sensory processing FRESHLY PREPARED SOLUTION 

Delta sleep-inducing peptide (DSIP) is a neuropeptide that has been investigated in experimental and preclinical research settings for its involvement in the regulation of multiple endocrine and physiological processes, particularly those related to sleep–wake modulation and adaptive stress responses. Experimental studies suggest that DSIP may be associated with: Modulation of sleep-related physiological processes Regulation of sleep quality under conditions of chronic sleep disruption Adaptive responses to physiological and psychological stress Influence on autonomic and cardiovascular regulatory parameters Modulation of pain-related sensory processing

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health   FRESHLY PREPARED SOLUTION 

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health  

1 box/5 Pieces

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission    FRESHLY PREPARED SOLUTION 

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission      

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

FOXO4-DRI is a research peptide investigated for its ability to selectively interact with cellular pathways associated with senescence. Preclinical studies suggest that modulation of senescent cell populations may support improvements in biological function and tissue-level homeostasis in experimental models of aging.  According to experimental and preclinical research observations, FOXO4-DRI has been associated with the following effects: Selective induction of apoptosis in senescent cells in laboratory models Improvement of physical performance parameters in aging animal studies Support of tissue and organ function markers in preclinical research Contribution to the restoration of tissue homeostasis under experimental conditions